Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

Mahnaz Arian; Mina AkbariRad; Ahmad Bagheri MoghaddamAbdollah FirooziMohammad Jami

首页> 外文期刊>Infectious disorders drug targets >Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

【24h】

Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

机译：Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相关主题

摘要

Allopurinol is an FDA -Approved xanthine oxidase inhibitor, which is effective in thetreatment of gout, hyperuricemia and uremic kidney stones in patients with an increased level ofuric acid excretion. Xanthine oxidase acts by converting hypoxanthine and xanthine into uric acid,and therefore its inhibition results in decreased production of uric acid. The most common side effectsof this medication are as follows: maculopapular rashes, hives, itching, headache, dizziness,abnormal hair loss, fever and hypersensitivity reaction.Case Presentation: This report represents a case of drug-induced meningitis of a senile man whoended up in the ICU due to the remarkably reduced state of consciousness.

著录项

来源
《Infectious disorders drug targets》 |2020年第2期|253-256|共4页
作者
Mahnaz Arian; Mina AkbariRad; Ahmad Bagheri MoghaddamAbdollah FirooziMohammad Jami;
展开▼
作者单位

Department of Infectious Diseases, Faculty of Medicine, Mashhad University of Medical Sciences;

Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences;

Department of Anesthesia, Faculty of Medicine, Mashhad University of Medical SciencesDepartment of Pharmaceutical Science, Mashhad University of Medical SciencesFaculty of Medicine, Mashhad University of Medical Sciences;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类药学;
关键词
Allopurinol; drug-induced meningitis; bacterial meningitis; consciousnes; gout; hyperuricemia;

Allopurinol and Loss of Consciousness in a 78-old Year Man Suffering from Gout

摘要

著录项

相关主题

期刊订阅